NCT06585969 2026-02-12
DISCORDANT
Danish Breast Cancer Cooperative Group
Phase 3 Withdrawn
Clinical Trials
75 trialsNCT07092475 2025-11-26
The Impact of Intraoperative Methadone on Postoperative Opioid Use
University of Utah
Phase 3 Withdrawn
NCT04488159 2024-09-20
iMAGINE
Medical University of Vienna
Phase 3 Withdrawn
NCT03747562 2024-09-19
stREnGTH
University Hospital, Ghent
Phase 3 Withdrawn
NCT05403580 2024-05-06
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
Mayo Clinic
Phase 3 Withdrawn
NCT05707702 2024-05-01
Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia
Boston Medical Center
Phase 3 Withdrawn
NCT06301308 2024-04-24
A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial
Second Xiangya Hospital of Central South University
Phase 3 Withdrawn
NCT04029857 2024-02-13
Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery
M.D. Anderson Cancer Center
Phase 3 Withdrawn
NCT02519140 2023-12-04
Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
Maimonides Medical Center
Phase 3 Withdrawn
NCT05771896 2023-09-14
CARE
GenesisCare USA
Phase 3 Withdrawn
NCT05098327 2023-08-15
Pioglitazone and Insulin Resistance in ADT
State University of New York at Buffalo
Phase 3 Withdrawn
NCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
NCT04676243 2022-05-25
Q-SOC
University Hospital Heidelberg
Phase 3 Withdrawn
NCT00255138 2022-04-01
Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects
Temple University
Phase 3 Withdrawn
NCT02848716 2021-11-17
LiLACs
Institut Claudius Regaud
Phase 3 Withdrawn
NCT03806049 2021-07-15
Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Phase 3 Withdrawn
NCT04288765 2021-07-09
Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma
Grupo Cooperativo de Hemopatías Malignas
Phase 3 Withdrawn
NCT03536182 2021-05-26
CIPHER
University of Texas Southwestern Medical Center
Phase 3 Withdrawn
NCT02326779 2021-04-27
Low-dose Aspirin Therapy for Esophageal Cancer
Zhejiang University
Phase 3 Withdrawn
NCT03066466 2021-04-27
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
Loyola University
Phase 3 Withdrawn
NCT03768869 2021-04-27
Fever and Neutropenia in Pediatric Oncology Patients
University of Colorado, Denver
Phase 3 Withdrawn
NCT03649035 2021-03-19
Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma
Istituto Clinico Humanitas
Phase 3 Withdrawn
NCT01906073 2020-12-10
NFCP-2
Norwegian University of Science and Technology
Phase 3 Withdrawn
NCT04225299 2020-11-13
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Steba Biotech S.A.
Phase 3 Withdrawn
NCT01826864 2020-07-27
Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma
Jonsson Comprehensive Cancer Center
Phase 3 Withdrawn
NCT04361552 2020-06-18
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
Emory University
Phase 3 Withdrawn
NCT03579758 2020-06-05
Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer
Emory University
Phase 3 Withdrawn
NCT00006451 2020-01-03
Bone Marrow Transplantation in Treating Patients With Leukemia
Masonic Cancer Center, University of Minnesota
Phase 3 Withdrawn
NCT01470742 2019-12-30
Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer
Samsung Medical Center
Phase 3 Withdrawn
NCT03298958 2019-06-12
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase 3 Withdrawn
NCT02736552 2019-05-08
Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.
Fudan University
Phase 3 Withdrawn
NCT03744247 2019-05-02
Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC
Sun Yat-sen University
Phase 3 Withdrawn
NCT03791918 2019-05-02
Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria
Sun Yat-sen University
Phase 3 Withdrawn
NCT02438852 2019-04-16
Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
University of Southern California
Phase 3 Withdrawn
NCT03355768 2018-12-19
Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL
Columbia University
Phase 3 Withdrawn
NCT02053311 2018-07-30
Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents
Swiss Cancer Institute
Phase 3 Withdrawn
NCT02149771 2018-04-19
Combination Treatment for Advanced Liver Cancer
Shanghai Zhongshan Hospital
Phase 3 Withdrawn
NCT01796444 2018-04-05
Z0011-China
Shandong Cancer Hospital and Institute
Phase 3 Withdrawn
NCT02269696 2018-03-22
The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients
Kuopio University Hospital
Phase 3 Withdrawn
NCT01032512 2018-02-19
Clinical Benefits of Preoperative Nutrition Support With Enteral Immune-enhancing Formulas in Surgical Oncology
University of Chile
Phase 3 Withdrawn
NCT02784730 2018-02-05
PICC One Day
Centre Leon Berard
Phase 3 Withdrawn
NCT01545687 2017-08-08
CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn
NCT01260103 2017-07-26
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Burzynski Research Institute
Phase 3 Withdrawn
NCT01951911 2017-07-11
KETA-1
Haukeland University Hospital
Phase 3 Withdrawn
NCT00695916 2017-02-01
MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery
Stanford University
Phase 3 Withdrawn
NCT02795884 2016-12-30
Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation
Yonsei University
Phase 3 Withdrawn
NCT02427893 2016-11-15
Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 3 Withdrawn
NCT02739243 2016-10-26
PREPARE
Heidelberg University
Phase 3 Withdrawn
NCT00041171 2016-07-12
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn
NCT00053339 2016-07-12
Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn